β-Aminoisobutyric acid ameliorates the renal fibrosis in mouse obstructed kidneys via inhibition of renal fibroblast activation and fibrosis

β-Aminoisobutyric acid ameliorates the renal fibrosis in mouse obstructed kidneys via inhibition of renal fibroblast activation and fibrosis

Renal fibrosis is a hallmark feature of chronic kidney disease, which is reflected by proliferation and migration of interstitial fibroblasts and extracellular matrix (ECM) accumulation. β-Aminoisobutyric acid (BAIBA) is recently demonstrated to exert a protective role from metabolic diseases. Howev...

Full description

Bibliographic Details
Main Authors:	Huijuan Wang, Jun Qian, Xiufen Zhao, Changing Xing, Bin Sun
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Series:	Journal of Pharmacological Sciences
Subjects:	β-Aminoisobutyric acid Angiotensin II Extracellular matrix Interleukin-17 Reactive oxygen species
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861317300038

Similar Items

Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine
by: Kouji Fukuyama, et al.
Published: (2023-05-01)

A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics
by: Kouji Fukuyama, et al.
Published: (2023-03-01)

β‑aminoisobutyric acid ameliorates hypertensive vascular remodeling via activating the AMPK/SIRT1 pathway in VSMCs
by: Bo Yin, et al.
Published: (2022-06-01)

β-aminoisobutyric Acid, l-BAIBA, Is a Muscle-Derived Osteocyte Survival Factor
by: Yukiko Kitase, et al.
Published: (2018-02-01)

A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
by: Kouji Fukuyama, et al.
Published: (2023-08-01)

Ets-1 Targeted by MicroRNA-221 Regulates Angiotensin II-Induced Renal Fibroblast Activation and Fibrosis
by: Jia Di, et al.
Published: (2014-09-01)

Sauchinone Protects Renal Mesangial Cell Dysfunction against Angiotensin II by Improving Renal Fibrosis and Inflammation
by: Jung Joo Yoon, et al.
Published: (2020-09-01)

Physiological competition of brain phenylalanine accretion: Initial pharmacokinetic analyses of aminoisobutyric and methylaminoisobutyric acids in Pahenu2−/− mice
by: Kara R. Vogel, et al.
Published: (2015-06-01)

Associations between plasma branched-chain amino acids, β-aminoisobutyric acid and body composition
by: Annemarie Rietman, et al.
Published: (2016-01-01)

Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity
by: Xinghua Qin, et al.
Published: (2024-02-01)

Crystal structure and hydrogen bonding in N-(1-deoxy-β-d-fructopyranos-1-yl)-2-aminoisobutyric acid
by: Valeri V. Mossine, et al.
Published: (2018-01-01)

Macrophage Depletion Lowered Blood Pressure and Attenuated Hypertensive Renal Injury and Fibrosis
by: Lei Huang, et al.
Published: (2018-05-01)

TIGAR deficiency sensitizes angiotensin‐II‐induced renal fibrosis and glomerular injury
by: Xiaochen He, et al.
Published: (2022-04-01)

The Effect of Losartan (AT1 Receptor Inhibitor) on Reactive Nitrogen Species and Renal Function after Renal Ischemia-reperfusion in Rat
by: Saeide Baarforoush, et al.
Published: (2016-04-01)

Neurovascular Coupling in Hypertension Is Impaired by IL-17A through Oxidative Stress
by: Jessica Youwakim, et al.
Published: (2023-02-01)

β-Aminoisobutyric acid, L-BAIBA, protects PC12 cells from hydrogen peroxide-induced oxidative stress and apoptosis via activation of the AMPK and PI3K/Akt pathway
by: Tomomi Minato, et al.
Published: (2022-06-01)

Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors
by: Satoshi Katano, et al.
Published: (2022-12-01)

Role of Nonclassical Renin-angiotensin system Axis In Renal Fibrosis
by: Linli eLv, et al.
Published: (2015-04-01)

A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis
by: Rahul Rai, et al.
Published: (2017-11-01)

Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis
by: Baihai Jiao, et al.
Published: (2021-08-01)

Role of bone marrow-derived fibroblasts in renal fibrosis
by: Jingyin eYan, et al.
Published: (2016-02-01)

Angiotensin II-Related Activation of Scleral Fibroblasts and Their Role on Retinal Ganglion Cell Death in Glaucoma
by: Si-Eun Oh, et al.
Published: (2023-04-01)

Angiotensin II: a key mediator in the development of liver fibrosis and cancer
by: Sameh Saber
Published: (2018-11-01)

Dual Activity of Ginsenoside Rb1 in Hypertrophic Cardiomyocytes and Activated Macrophages: Implications for the Therapeutic Intervention of Cardiac Hypertrophy
by: Wang S, et al.
Published: (2021-05-01)

Renal actions of angiotensin-(1-7)
by: A.C. Simões-e-Silva, et al.
Published: (1997-04-01)

Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis
by: Jixiu Jin, et al.
Published: (2020-10-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Targeting hepatic oxidative stress rescues bone loss in liver fibrosis
by: Soichiro Sonoda, et al.
Published: (2022-12-01)

Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
by: Yun-Juan Nie, et al.
Published: (2022-05-01)

The Role of Angiotensin II Infusion on the Baroreflex Sensitivity and Renal Function in Intact and Bilateral Renal Denervation Rats
by: Mohammad Karim Azadbakht, et al.
Published: (2018-01-01)

Roles of mitogen-activated protein kinases and angiotensin II in renal development
by: A.P.C. Balbi, et al.
Published: (2009-01-01)

IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?
by: Aurore Devocelle, et al.
Published: (2021-10-01)

Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
by: M. Olszowiec-Chlebna, et al.
Published: (2019-03-01)

Regulation of the renal proximal tubule second sodium pump by angiotensins
by: C. Caruso-Neves, et al.
Published: (2001-08-01)

Pulmonary midkine inhibition ameliorates sepsis induced lung injury
by: Jing-Yuan Xu, et al.
Published: (2021-02-01)

Role of angiotensin II and neuroendocrine factors in immunological regulation in patients with coronary heart disease: prospective cross-sectional study
by: Vladimir K. Parfenyuk, et al.
Published: (2023-12-01)

Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II–Treated Mice
by: Jing Ye, et al.
Published: (2017-10-01)

Correlation with renin-angiotensin-aldosterone and glomerular filtration rate in chronic renal failure patients
by: Fatimah Kadhim Ibrahim AL-Mahdawi ,, et al.
Published: (2023-06-01)

3,3′-Diindolylmethane ameliorates renal fibrosis through the inhibition of renal fibroblast activation in vivo and in vitro
by: Zun-En Xia, et al.
Published: (2018-10-01)

Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists
by: Han Siean Lee, et al.
Published: (2020-10-01)